0      0

AONN+ Annual 2021 Virtual Conference

FRI13 - Industry Sponsored Session |Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings Presented by Lilly PP-AL-US-2989 © LillyUSA, LLC 2021. All rights reserved.

Nov 19, 2021 4:15pm ‐ Nov 19, 2021 5:15pm


  • Blanca Ledezma, MSN, NP, Nurse Practitioner, UCLA Santa Monica Hematology/Oncology

You must be logged in and own this session in order to post comments.